Interest in precision diagnostics has been fuelled by the concept that early detection of
cancer would benefit patients; that is, if detected early, more tumours should be resectable …

Pancreatic cancer (PC) is a leading cause of cancer related mortality on a global scale. The
disease itself is associated with a dismal prognosis, partly due to its silent nature resulting in …

Pancreatic cancer is a lethal malignancy with its incidence almost equivalent to mortality.
The complex pathophysiology, absence of early diagnostic and prognostic markers and …

Effective prevention and management of osteoporosis would require suitable methods for
population screenings and early diagnosis. Current clinically-available diagnostic methods …

Purpose Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, with a 5-year
survival of< 10% because of diffuse symptoms leading to late-stage diagnosis. That survival …

Pancreatic cancer is currently the most lethal tumor entity and case numbers are rising. It will
soon be the second most frequent cause of cancer-related death in the Western world …

Pancreatic ductal adenocarcinoma (PDAC) represents the fourth cause of death in cancer
and has a 5-year survival of< 5%. Only about 15% of the patients present with a resectable …

Background: CA19-9, which is currently in clinical use as a pancreatic ductal
adenocarcinoma (PDAC) biomarker, has limited performance in detecting early-stage …

Background: To improve the prognosis of patients with pancreatic cancer, more accurate
serum diagnostic methods are required. We used serum metabolomics as a diagnostic …

The concept of antibody microarrays is one of the most versatile approaches within
multiplexed immunoassay technologies. These types of arrays have increasingly become an …